Emerging Therapies for Acute Coronary Syndromes

In the majority of cases acute coronary syndromes (ACS) are caused by activation and aggregation of platelets and subsequent thrombus formation leading to a decrease in coronary artery blood flow. Recent focus on the treatment of ACS has centered on reducing the response of platelets to vascular inj...

Descripción completa

Detalles Bibliográficos
Autores principales: Lilly, Scott M., Wilensky, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199568/
https://www.ncbi.nlm.nih.gov/pubmed/22028691
http://dx.doi.org/10.3389/fphar.2011.00061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199568/
https://www.ncbi.nlm.nih.gov/pubmed/22028691
http://dx.doi.org/10.3389/fphar.2011.00061

Ejemplares similares